Demystifying Cancer Immunotherapy: How Checkpoint Inhibitors Empower the Immune System
Understanding how modern checkpoint inhibitors work, which cancers benefit most, and managing immune-related side effects.
Dr. Chinmayee Agrawal is a European Certified Medical Oncologist (ECMO) and dual-trained oncology specialist with advanced DM in Medical Oncology and MD in Radiation Oncology. She specializes in precision cancer therapies, targeted treatment, immunotherapy, and haematological malignancies.
Years Experience
Happy Patients
Satisfaction Rate
Dr. Chinmayee Agrawal is a dual-trained oncology specialist holding an MD in Radiation Oncology as well as a DM in Medical Oncology from Ramaiah Medical College, Bengaluru. In 2023, she earned the European Certified Medical Oncologist (ECMO) qualification from ESMO.
Every cancer journey is unique. My commitment is to deliver modern, scientifically validated, and individualized cancer therapies while ensuring dignity, clear communication, and unyielding support for patients and their families.
Advanced systemic cytotoxic protocols tailored to specific tumor histology, administered with modern antiemetic premedications, precision organ-protective dosing, and expert daycare monitoring.
Cutting-edge biological therapies utilizing immune checkpoint inhibitors (anti-PD-1, anti-PD-L1, CTLA-4) to empower the patient’s own immune system to identify, target, and destroy cancer cells.
Next-generation molecular therapies designed to selectively inhibit oncogenic driver mutations (EGFR, ALK, ROS1, HER2, BRAF, BRCA) while sparing healthy normal cells.
Rigorous histological re-evaluation, PET-CT and MRI staging validation, next-generation sequencing (NGS) analysis, and transparent second opinions for uncompromised diagnostic accuracy.
Holistic supportive oncology focusing on WHO analgesic ladder pain control, management of treatment-related toxicities, nutritional restoration, and comprehensive palliative comfort care.
Full-spectrum cancer journey coordination integrating outpatient daycare chemotherapy, molecular testing, multi-specialty tumor boards, and long-term survivorship monitoring.
Personalized management of hormone receptor-positive (HR+), HER2-enriched, and Triple-Negative Breast Cancer (TNBC) utilizing CDK4/6 inhibitors, targeted antibody-drug conjugates, and evidence-based chemotherapy.
Comprehensive medical oncology care for high-grade serous, clear cell, and endometrioid ovarian cancers, featuring platinum-based chemotherapy, bevacizumab angiogenesis inhibition, and BRCA/HRD-directed PARP maintenance.
Specialized systemic regimens for squamous cell and adenocarcinoma of the cervix, combining concurrent radiosensitizing cisplatin, targeted VEGF inhibition, and immune checkpoint blockade.
Expert management of haematological malignancies including Acute/Chronic Leukemias, Hodgkin & Non-Hodgkin Lymphomas, and Multiple Myeloma through targeted immunochemotherapy and transplant coordination.
Comprehensive next-generation sequencing driven targeted therapy (EGFR, ALK, ROS1, KRAS G12C, MET, RET) and frontline chemo-immunotherapy protocols for thoracic and lung malignancies.
Independent, thorough clinical re-evaluation of pathology slides, PET-CT staging, and proposed therapeutic strategies by a European Certified Medical Oncologist (ECMO) ensuring total confidence.
Our clinical team reviews biopsy, PET-CT, and molecular pathology reports to formulate individualized roadmaps.
Grounded in rigorous training, clinical expertise, and continuous growth.
Administration of chemotherapy, targeted therapy and immunotherapy in solid malignancy and haemato-lymphoid malignancy. Research activities and teaching of Resident Medical Officers and departmental nurses.
Administration of chemotherapy, targeted therapy and immunotherapy in solid malignancy and haemato-lymphoid malignancy. Research activities, teaching of RMOs and nurses, and actively involved in setting up the Oncology Department.
Administration of chemotherapy, targeted therapy and immunotherapy in solid malignancy and haemato-lymphoid malignancy. Departmental teaching and active role in oncology service expansion.
Administration of systemic cancer chemotherapy, targeted therapy, and immunotherapy protocols.
Real feedback from patients whose lives were touched by compassionate, expert cancer care.
Dr. Chinmayee Agrawal took the time to explain every detail of my motherÔÇÖs diagnosis with patience and clarity. She laid out the treatment roadmap clearly without creating unnecessary fear.
Her dual expertise in both radiation and medical oncology made us feel confident that no stone was left unturned. The nursing staff and support protocols kept side effects well managed.
From our very first visit, Dr. Chinmayee Agrawal was compassionate, accessible, and scientifically thorough. She walked us through the genetic testing reports with immense care.
Whether you are starting a new treatment plan, exploring targeted or immunotherapy options, or seeking an informed second opinion, schedule a personalized clinical consultation today.
Evidence-based health insights, research summaries, and wellness guidance from my practice.
Understanding how modern checkpoint inhibitors work, which cancers benefit most, and managing immune-related side effects.
A look into high-sensitivity flow cytometry and molecular testing to detect residual leukemic cells and guide treatment.
How estrogen, progesterone, and HER2 receptor status guide individualized therapy across different patient age groups.